Literature DB >> 14709376

Lipid-lowering drugs and homocysteine. A comparison between statins and other lipid-lowering drugs.

Piotr Jankowski, Kalina Kawecka-Jaszcz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14709376     DOI： 10.1016/j.atherosclerosis.2003.09.004

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  2 in total

1.  Interactions between the single nucleotide polymorphisms in the homocysteine pathway (MTHFR 677C>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study.

Authors:  Anke-Hilse Maitland-van der Zee; Amy Lynch; Eric Boerwinkle; Donna K Arnett; Barry R Davis; Catherine Leiendecker-Foster; Charles E Ford; John H Eckfeldt
Journal:  Pharmacogenet Genomics       Date:  2008-08       Impact factor: 2.089

2.  Changes in Homocysteine Levels Affect Serum Lipid Response to Atorvastatin in Patients With Acute Coronary Syndrome: A Retrospective Observational Study.

Authors:  Dong-Feng Wu; Yin-Xiong Wu; Jin-Long Deng
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.